Krystal Biotech is providing this tool to help patients find healthcare professionals in their area who are knowledgeable about managing DEB. Selecting a healthcare professional is an important decision that you should consider carefully. This tool is just one source of information available to you.
Results will display here once you select filters and click to search.
*No fees have been received by or paid to healthcare professionals in exchange for inclusion in this directory. Inclusion in this directory does not represent an endorsement or recommendation from Krystal Biotech nor do any of these healthcare professionals necessarily prescribe or endorse any Krystal Biotech products. The results shown may not be inclusive of all healthcare professionals who may have experience with DEB in your area.
If you are a healthcare professional and you would like to be removed from this directory, please email us at [email protected] and provide your first and last name and NPI number.
If you are a healthcare professional and you would like to be included in this directory, please email us at [email protected] and provide your first and last name, specialty, practice address(es) and practice phone number(s).
VYJUVEK is a topical gel used to treat wounds in patients 6 months and older with dystrophic epidermolysis bullosa (DEB).
VYJUVEK gel must be applied by a healthcare provider.
After treatment, patients and caregivers should be careful not to touch treated wounds and dressings for 24 hours. If accidentally exposed to the VYJUVEK gel, clean the affected area.
Wash hands and wear protective gloves when changing wound dressings. Disinfect bandages from the first dressing change with a virucidal agent, and dispose of the disinfected bandages in a separate sealed plastic bag in household waste. Dispose of the subsequent used dressings in a sealed plastic bag in household waste.
Patients should avoid touching or scratching wound sites or wound dressings.
The most common adverse reactions (>5%) were itching, chills, redness, rash, cough, and runny nose. These are not all the possible side effects with VYJUVEK. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or to the Sponsor at 1-844-557-9782.
VYJUVEK is a topical gel used to treat wounds in patients 6 months and older with dystrophic epidermolysis bullosa (DEB).
VYJUVEK gel must be applied by a healthcare provider.
After treatment, patients and caregivers should be careful not to touch treated wounds and dressings for 24 hours. If accidentally exposed to the VYJUVEK gel, clean the affected area.
Wash hands and wear protective gloves when changing wound dressings. Disinfect bandages from the first dressing change with a virucidal agent, and dispose of the disinfected bandages in a separate sealed plastic bag in household waste. Dispose of the subsequent used dressings in a sealed plastic bag in household waste.
Patients should avoid touching or scratching wound sites or wound dressings.
The most common adverse reactions (>5%) were itching, chills, redness, rash, cough, and runny nose. These are not all the possible side effects with VYJUVEK. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or to the Sponsor at 1-844-557-9782.
You are about to leave the VYJUVEK.com website
Are you sure you want to leave?
